Inactivated and live, attenuated poliovirus vaccines: mucosal immunity.
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using data from one of these studies [17], it has been noted that the combined reduction in both the quantity and duration of vaccine poliovirus shedding would reduce the total amount of poliovirus shed during the course of an infection by approximately 95% [15].”
From Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge (2012) · cites this paper as [15]
In the citing paper
“A number of review articles have examined some of the larger OPV challenge studies [2], [14], [15], but we are not aware of any attempt at a systematic review of the large and heterogeneous group of published studies.”
From Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge (2012) · cites this paper as [15]
Citations
Cites
Mendelsohn, C. L., Wimmer, E., & Racaniello, V. R. (1989) · Cell · doi:10.1016/0092-8674(89)90690-9 · Cited by 1,111
Owen, R. L., & Jones, A. L. (1974) · Gastroenterology · doi:10.1016/s0016-5085(74)80102-2 · Cited by 762
Owen, R. L. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80254-0 · Cited by 669
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.
Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453
Self-citationOgra, P. L., Karzon, D. T., Righthand, F., & MacGillivray, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196810242791701 · Cited by 397
Expanded Programme on Immunization
(2001) · Immunization · doi:10.1002/9780470693841.ch8 · Cited by 392
Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines
Onorato, I. M., Modlin, J. F., McBean, A. M., Thoms, M. L., Losonsky, G. A., & Bernier, R. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.1 · Cited by 246
Poliovirus type 1 enters the human host through intestinal M cells
Siciński, P., Rowiński, J., Warchoł, J. B., Jarząbek, Z., Gut, W., Szczygieł, B., Bielecki, K., & Koch, G. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91290-m · Cited by 216
Hovi, T., Huovilainen, A., Kuronen, T., Pöyry, T., Salama, N., Cantell, K., Kinnunen, E., Lapinleimu, K., Roivainen, M., Stenvik, M., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91566-7 · Cited by 186
Faden, H., Modlin, J. F., Thoms, M. L., McBean, A. M., Ferdon, M. B., & Ogra, P. L. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1291 · Cited by 178
Research works printed but not linked: 8
- Institute of Medicine (1988) An evaluation of poliomyelitis vaccine policy options. Washington, DC: National Academy of Sciences (Publication No. IOM 88-04)
- Ogra PL, Karzon DT (1971) Formation and function of poliovirus antibody in different tissues. Prog Med Virol 13: 156–193
- Centers for Disease Control (1986) Update: Poliomyelitis outbreak -Finland, 1984–1985. MMWR 35: 82–86
- Ogra P (1970) The role of nasopharyngeal tonsils and adenoids in the mechanism of mucosal immunity to poliovirus. American Pediatric Society, 80th Annual Meeting, Program and Abstracts
- Isacson P, Melnick JL, Walton M (1957) Environmental studies of endemic enteric viral infections. II. Poliovirus infections in household units. Am J Hygiene 65: 29–42
- Expanded Programme on Immunization, Pan American Health Organization (1990) Surveillance of wild poliovirus in the Americas. EPI Newsletter 12: 1–3
- World Health Organization (1988) Global eradication of poliomyelitis by the year 2000. Weekly Epidemiol Rec 63: 161–162
- Ogra PL, Karzon DT, Righthand F, MacGillivray M (1968) Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med 279: 893–900 · DOI · Paper page
Cited by
Robbins, J. B., Schneerson, R., & Szu, S. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1387 · Cited by 385
“nized with an improved formalin-inactivated poliovirus vaccine (EIPV or Salk-type) [135, 136] for -30 years; compliance is almost 100(^.”
MethodHird, T. R., & Grassly, N. C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002599 · Cited by 221
“Using data from one of these studies [17], it has been noted that the combined reduction in both the quantity and duration of vaccine poliovirus shedding would reduce the total amount of poliovirus shed during the course of an infection by approximately 95% [15].”
BackgroundMethodSutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Self-citationEstívariz, C. F., Jafari, H. S., Sutter, R. W., John, T. J., Jain, V., Agarwal, A., Verma, H., Pallansch, M. A., Singh, A. P., Guirguis, S., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70190-6 · Cited by 98
Self-citation
Metadata
- Authors
- Sutter, R. W., & Patriarca, P. A.
- Affiliations
- Centers for Disease Control and Prevention (US)
- ORCID
- Sutter, R. W.
- Venue
- Measles and Poliomyelitis
- Publisher
- Springer Vienna
- Published
- 1993
- Pages
- 279-294
- OpenAlex
- W2234200170
- Cited by
- 23
- References
- 67
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 1 · 2017: 2 · 2015: 1 · 2013: 6 · 2012: 2
- FWCI
- 7.42
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Springer eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- polio vaccine, inactivated poliovirus vaccine, oral polio vaccine, mucosal immunity, secretory IgA, fecal excretion, humoral immunity, polio eradication, community protection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inactivated and live, attenuated poliovirus vaccines: mucosal immunity. https://app.cochat.ai/papers/10.1007/978-3-7091-9278-8_23
- The paper
- Sutter, R. W., & Patriarca, P. A. (1993). Inactivated and live, attenuated poliovirus vaccines: mucosal immunity. Measles and Poliomyelitis. https://doi.org/10.1007/978-3-7091-9278-8_23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.